The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med. 2012 Feb 21; 156(4):263-70.